tradingkey.logo

SI-BONE Inc

SIBN
15.590USD
-0.130-0.83%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
674.63MMarktkapitalisierung
VerlustKGV TTM

SI-BONE Inc

15.590
-0.130-0.83%

mehr Informationen über SI-BONE Inc Unternehmen

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

SI-BONE Inc Informationen

BörsenkürzelSIBN
Name des UnternehmensSI-BONE Inc
IPO-datumOct 17, 2018
CEOFrancis (Laura A)
Anzahl der mitarbeiter349
WertpapierartOrdinary Share
GeschäftsjahresendeOct 17
Addresse471 El Camino Real, Suite 101
StadtSANTA CLARA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl95050
Telefon14082070700
Websitehttps://si-bone.com/
BörsenkürzelSIBN
IPO-datumOct 17, 2018
CEOFrancis (Laura A)

Führungskräfte von SI-BONE Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+8675.00%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
115.97K
-337.00%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+8675.00%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+8675.00%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
14.64K
-7361.00%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+8675.00%
Ms. Laura A. Francis
Ms. Laura A. Francis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Michael A. Pisetsky
Mr. Michael A. Pisetsky
Secretary, Chief Business & Legal Affairs Officer
Secretary, Chief Business & Legal Affairs Officer
--
--
Mr. Anthony J. Recupero, Ph.D.
Mr. Anthony J. Recupero, Ph.D.
President - Commercial Operations
President - Commercial Operations
--
--
Mr. Timothy E. (Ted) Davis, Jr.
Mr. Timothy E. (Ted) Davis, Jr.
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+8675.00%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
115.97K
-337.00%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+8675.00%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+8675.00%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
14.64K
-7361.00%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+8675.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
46.37M
95.30%
International
2.29M
4.70%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
First Light Asset Management, LLC
11.63%
BlackRock Institutional Trust Company, N.A.
6.75%
American Century Investment Management, Inc.
6.54%
Brown Advisory
6.39%
OrbiMed Advisors, LLC
5.94%
Andere
62.74%
Aktionäre
Aktionäre
Anteil
First Light Asset Management, LLC
11.63%
BlackRock Institutional Trust Company, N.A.
6.75%
American Century Investment Management, Inc.
6.54%
Brown Advisory
6.39%
OrbiMed Advisors, LLC
5.94%
Andere
62.74%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
44.12%
Investment Advisor/Hedge Fund
40.89%
Hedge Fund
12.72%
Private Equity
5.94%
Individual Investor
3.13%
Research Firm
2.80%
Bank and Trust
0.28%
Pension Fund
0.18%
Venture Capital
0.08%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
361
46.32M
106.74%
+1.27M
2025Q3
361
41.74M
96.76%
-3.86M
2025Q2
375
42.98M
99.64%
-3.69M
2025Q1
387
43.81M
102.83%
-3.10M
2024Q4
376
42.78M
100.80%
-4.52M
2024Q3
370
42.61M
102.18%
-5.88M
2024Q2
364
42.74M
103.69%
-5.64M
2024Q1
363
42.76M
104.26%
-3.79M
2023Q4
363
41.07M
101.66%
-4.86M
2023Q3
356
41.24M
102.85%
-4.82M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
First Light Asset Management, LLC
5.05M
11.63%
+3.13M
+163.10%
Nov 30, 2025
BlackRock Institutional Trust Company, N.A.
2.93M
6.75%
-38.60K
-1.30%
Sep 30, 2025
American Century Investment Management, Inc.
2.84M
6.54%
+521.68K
+22.52%
Sep 30, 2025
Brown Advisory
2.77M
6.39%
-139.81K
-4.80%
Sep 30, 2025
OrbiMed Advisors, LLC
2.58M
5.94%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
2.48M
5.72%
+41.45K
+1.70%
Sep 30, 2025
Champlain Investment Partners, LLC
2.11M
4.86%
-31.13K
-1.45%
Sep 30, 2025
Silvercrest Asset Management Group LLC
1.46M
3.37%
-19.97K
-1.35%
Sep 30, 2025
Impax Asset Management LLC
1.03M
2.36%
+333.25K
+48.17%
Sep 30, 2025
Granahan Investment Management, LLC
1.04M
2.4%
-224.68K
-17.77%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
0.87%
Hypatia Women CEO ETF
0.54%
Invesco NASDAQ Future Gen 200 ETF
0.48%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.1%
Principal U.S. Small-Cap ETF
0.08%
iShares U.S. Medical Devices ETF
0.07%
First Trust Active Factor Small Cap ETF
0.04%
iShares Russell 2000 Growth ETF
0.03%
Vanguard US Momentum Factor ETF
0.03%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil0.87%
Hypatia Women CEO ETF
Anteil0.54%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.48%
iShares Micro-Cap ETF
Anteil0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.1%
Principal U.S. Small-Cap ETF
Anteil0.08%
iShares U.S. Medical Devices ETF
Anteil0.07%
First Trust Active Factor Small Cap ETF
Anteil0.04%
iShares Russell 2000 Growth ETF
Anteil0.03%
Vanguard US Momentum Factor ETF
Anteil0.03%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI